Kelvin Varghese helps clients build and manage domestic and international patent portfolios. He prepares and prosecutes patent applications covering a wide range of technologies. One area of Kelvin's focus is on medical devices, including intravascular catheters and guide wires, ultrasound transducers, ophthalmologic surgical instruments, and orthopedic implants and prosthetics. He works with patents related to the structure of medical devices, processing hardware and software, and diagnostic and therapeutic methods, among others. Kelvin also counsels clients regarding product clearance and patent infringement issues, including preparation of invalidity and non-infringement opinions. His practice also includes post-issuance proceedings at the U.S. Patent and Trademark Office.

During law school, Kelvin was Executive Editor of the Federal Circuit Bar Journal, which publishes articles on patent law decisions by the U.S. Court of Appeals for the Federal Circuit.

Kelvin completed an internship at the U.S. Patent & Trademark Office. He worked in the Office of Patent Legal Administration, which decides how examiners should apply the law when examining patent applications.

In addition to his law degree, Kelvin holds a B.S. in physics and minors in mathematics, chemistry, and political science.

Show More
Expand All
Professional Affiliations and Engagements
  • Texas Life Science Forum
  • BioHouston
  • United Way Young Leaders
Publications and Speaking Engagements
Qualifications

Education

J.D., George Washington University Law School, 2011, with honors; Executive Editor, Federal Circuit Bar Journal

B.S., Physics, Southern Methodist University, 2008, summa cum laude, Phi Beta Kappa

Clerkships

Intern, Hon. Barbara M.G. Lynn, U.S. District Court (N.D. Tex.)

Intern, Hon. Russell F. Canan, D.C. Superior Court

Admissions

Texas

U.S. Patent and Trademark Office

Publication
Kelvin Varghese Authored Article in Law360: ‘USPTO Pilot Program May Bring Welcome If Limited Effici [...]
January 20, 2022

The U.S. Patent and Trademark Office has announced a new pilot program that allows an applicant to defer responding to a subject matter eligibility, or SME, rejection under Title 35 of the U.S. Code, Section 101, during prosecution of a patent application.[1]   As part of the Deferred Subject Matter Eligibility Response, or DSMER, Pilot Program, the applicant can respond to a nonfinal office actio [...]